Boxer Capital Management
$1.3B 13F equity value
66 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Boxer Capital Management covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| TNGX | TANGO THERAPEUTICS INC | 10,876,219 | $340M | 25.6% |
| RVMD | REVOLUTION MEDICINES INC | 500,000 | $94M | 7.1% |
| ABVX | ABIVAX SA | 605,000 | $81M | 6.1% |
| QURE | UNIQURE NV | 1,503,300 | $69M | 5.2% |
| KOD | KODIAK SCIENCES INC | 1,477,600 | $58M | 4.3% |
| KYMR | KYMERA THERAPEUTICS INC | 429,100 | $49M | 3.7% |
| DFTX | DEFINIUM THERAPEUTICS INC | 998,500 | $47M | 3.5% |
| REPL | REPLIMUNE GROUP INC | 3,983,000 | $44M | 3.3% |
| CELC | CELCUITY INC | 416,530 | $44M | 3.3% |
| QTTB | Q32 BIO INC | 3,149,310 | $40M | 3.0% |
Track Boxer Capital Management's 13F portfolio: $1.3B in reported holdings, 66 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}